All Type of News
Confirmation Made on Successive Rollout of Bioequivalence Testing Requirement
The Regulatory Reform Committee recently announced of the final recommendations generated from the extra deliberation session on the amendment proposals to the Korea Pharmaceutical Affairs Law.
Among the various dr...
KFDA Makes Joint Collaboration Agreement with Consumer Protection Board Towards Public Safety
The Korea Food and Drug Administration (KFDA) recently made a joint collaboration agreement with the Korea Consumer Protection Board (KCPB), under an initiative to jointly promote the public welfare and trust on the h...
Focus on Pharmaceutical R&D Investments Recommended
The research on the strategic growth roadmap for the domestic pharmaceutical manufacturing industry suggests that there are lessons to be learned from Ranbaxy Laboratories Ltd. of India, in order for the domestic firm...
Cumulative Inventory Return Project Makes Stagnant Progress
The nationwide project coordinated by the Korea Pharmaceutical Association (KPA) on the return of unused cumulative pharmaceutical inventories is not being well executed, according to the retail pharmacist community.
...
ZPK Announces Financial Results for Year 2004
Zuellig Pharma Korea (ZPK) announced of its financial performance results for Year 2004, in which the company reported the sales of 22.9 billion won, up by 6.1% from the prior fiscal period.
From the results announ...
Survey Results Indicate Lack of Public Awareness on Glaucoma
The analysis on the results obtained from the nationwide survey indicates that the majority of adults in the nation are not well aware of glaucoma, a condition in which there is too much fluid pressure in the eye, cau...
KFDA Views Hanmi's Anti-obesity Drug Slimer as Generic Version
The Korea Food and Drug Administration (KFDA) recently expressed of its position to recognize Hanmi Pharmaceutical's anti-obesity drug Slimer as an equivalent generic version to the original drug Reductil by Abbott Ko...
Government Supports Continuous Retail Cigarette Price Increase
The government recently affirmed of its position to support the continuous retail price increases on the cigarettes, in order to make an effective undertaking of its anti-smoking policy geared to the public health pro...
KFDA Communicates Potential Safety Risks with Atopic Dermatitis Treatments
The Korea Food and Drug Administration (KFDA) made a communication on the potential safety risks that are associated with pimecrolimus and tacrolimus, both which are indicated for treatment of atopic dermatitis (AD), ...
Dongkook Wins Patent from Japan for Leuprolin Acetate Preparation
Dongkook Pharmaceutical announced that it has successfully obtained a patent from Japan for the company's proprietary preparation technology of leuprolin acetate, which is marketed under the tradename Lorelin Depot In...
